Literature DB >> 31218648

Human colorectal cancer derived-MSCs promote tumor cells escape from senescence via P53/P21 pathway.

G Li1, R Zhang1, X Zhang1, S Shao1, F Hu1, Y Feng2.   

Abstract

PURPOSE: The purpose of this study was to evaluate effect of MSCs on CRC cell.
METHODS: in this study the MSC was isolated from CRC tissue, its effect on CRC cells was investigated in vivo and vitro, and the underlying mechanism was investigated.
RESULTS: In this study we found that MSC-CM could promote colorectal cancer cells escape from senescence both in vitro and in vivo. Further research we demonstrated that MSC-CM acted in colorectal cancer cells senescence through P53/P21 pathway. Next we found that MSC-CM regulate P53 via posttranscription method.
CONCLUSION: Collectively, these results reveal that MSCs can help colorectal cancer cells defend against senescence through P53/P21 pathway, which may be a new strategy for colorectal cancer therapy.

Entities:  

Keywords:  Colorectal cancer; Mesenchymal stem cell; P53/p21; Senescence

Mesh:

Substances:

Year:  2019        PMID: 31218648     DOI: 10.1007/s12094-019-02152-5

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN: 1699-048X            Impact factor:   3.405


  27 in total

1.  Restoration of p53 function leads to tumour regression in vivo.

Authors:  Andrea Ventura; David G Kirsch; Margaret E McLaughlin; David A Tuveson; Jan Grimm; Laura Lintault; Jamie Newman; Elizabeth E Reczek; Ralph Weissleder; Tyler Jacks
Journal:  Nature       Date:  2007-01-24       Impact factor: 49.962

2.  Enhancing chemotherapy efficacy in Pten-deficient prostate tumors by activating the senescence-associated antitumor immunity.

Authors:  Alberto Toso; Ajinkya Revandkar; Diletta Di Mitri; Ilaria Guccini; Michele Proietti; Manuela Sarti; Sandra Pinton; Jiangwen Zhang; Madhuri Kalathur; Gianluca Civenni; David Jarrossay; Erica Montani; Camilla Marini; Ramon Garcia-Escudero; Eugenio Scanziani; Fabio Grassi; Pier Paolo Pandolfi; Carlo V Catapano; Andrea Alimonti
Journal:  Cell Rep       Date:  2014-09-25       Impact factor: 9.423

Review 3.  Tumour-associated mesenchymal stem/stromal cells: emerging therapeutic targets.

Authors:  Yufang Shi; Liming Du; Liangyu Lin; Ying Wang
Journal:  Nat Rev Drug Discov       Date:  2016-11-04       Impact factor: 84.694

Review 4.  Immunobiology of human mesenchymal stem cells and future use in hematopoietic stem cell transplantation.

Authors:  Katarina Le Blanc; Olle Ringdén
Journal:  Biol Blood Marrow Transplant       Date:  2005-05       Impact factor: 5.742

5.  Multilineage potential of adult human mesenchymal stem cells.

Authors:  M F Pittenger; A M Mackay; S C Beck; R K Jaiswal; R Douglas; J D Mosca; M A Moorman; D W Simonetti; S Craig; D R Marshak
Journal:  Science       Date:  1999-04-02       Impact factor: 47.728

6.  Myogenic cells derived from rat bone marrow mesenchymal stem cells exposed to 5-azacytidine.

Authors:  S Wakitani; T Saito; A I Caplan
Journal:  Muscle Nerve       Date:  1995-12       Impact factor: 3.217

Review 7.  Concise review: adult multipotent stromal cells and cancer: risk or benefit?

Authors:  Gwendal Lazennec; Christian Jorgensen
Journal:  Stem Cells       Date:  2008-04-03       Impact factor: 6.277

Review 8.  Cord blood stem cells: a review of potential neurological applications.

Authors:  David T Harris
Journal:  Stem Cell Rev       Date:  2008-08-05       Impact factor: 5.739

Review 9.  Cellular senescence: its role in tumor suppression and aging.

Authors:  Naoko Ohtani; David J Mann; Eiji Hara
Journal:  Cancer Sci       Date:  2009-03-15       Impact factor: 6.716

10.  Human colorectal cancer-derived mesenchymal stem cells promote colorectal cancer progression through IL-6/JAK2/STAT3 signaling.

Authors:  Xiaochao Zhang; Fayong Hu; Geng Li; Guodong Li; Xi Yang; Liang Liu; Rongsheng Zhang; Bixiang Zhang; Yongdong Feng
Journal:  Cell Death Dis       Date:  2018-01-18       Impact factor: 8.469

View more
  3 in total

Review 1.  TA-MSCs, TA-MSCs-EVs, MIF: their crosstalk in immunosuppressive tumor microenvironment.

Authors:  Zhenghou Zhang; Xiangyu Zhou; Jinshuai Guo; Fusheng Zhang; Yiping Qian; Guang Wang; Meiqi Duan; Yutian Wang; Haiying Zhao; Zhi Yang; Zunpeng Liu; Xiaofeng Jiang
Journal:  J Transl Med       Date:  2022-07-16       Impact factor: 8.440

2.  Gastric cancer mesenchymal stem cells regulate PD-L1-CTCF enhancing cancer stem cell-like properties and tumorigenesis.

Authors:  Li Sun; Chao Huang; Miaolin Zhu; Shuwei Guo; Qiuzhi Gao; Qianqian Wang; Bin Chen; Rong Li; Yuanyuan Zhao; Mei Wang; Zhihong Chen; Bo Shen; Wei Zhu
Journal:  Theranostics       Date:  2020-10-25       Impact factor: 11.556

Review 3.  The Effects of Mesenchymal Stem Cell on Colorectal Cancer.

Authors:  Jintao Yuan; Zhiping Wei; Xinwei Xu; Dickson Kofi Wiredu Ocansey; Xiu Cai; Fei Mao
Journal:  Stem Cells Int       Date:  2021-07-24       Impact factor: 5.443

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.